quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·1478d
PRRelease
Oaktree Acquisition Corp. II logo

Alvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVie

OACB· Oaktree Acquisition Corp. II
Finance
Original source

Companies

  • OACB
    Oaktree Acquisition Corp. II
    Finance

Recent analyst ratings

  • Mar 21UpdateNorthland Capital$15.00

Related

  • PR524d
    Certain Closed-end Funds Advised by Franklin Templeton Fund Adviser, LLC Announce Appointment of New Chair and Directors
  • SEC1408d
    SEC Form 25 filed by Oaktree Acquisition Corp. II
  • NEWS1414d
    Stocks That Hit 52-Week Lows On Thursday
  • SEC1416d
    Oaktree Acquisition Corp. II filed SEC Form 8-K: Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
  • PR1416d
    Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination
  • SEC1420d
    Oaktree Acquisition Corp. II filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
  • PR1420d
    Oaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Alvotech
  • NEWS1421d
    Stocks That Hit 52-Week Lows On Thursday
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022